3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia

Introduction: 3,4‐diaminopyridine has been used to treat Lambert‐Eaton myasthenia (LEM) for 30 years despite the lack of conclusive evidence of efficacy. Methods: We conducted a randomized double‐blind placebo‐controlled withdrawal study in patients with LEM who had been on stable regimens of 3,4‐di...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanders, Donald B., Juel, Vern C., Harati, Yadollah, Smith, A. Gordon, Peltier, Amanda C., Marburger, Tessa, Lou, Jau‐Shin, Pascuzzi, Robert M., Richman, David P., Xie, Tai, Demmel, Valentin, Jacobus, Laura R., Aleš, Kathy L., Jacobus, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900968/
https://www.ncbi.nlm.nih.gov/pubmed/29280483
http://dx.doi.org/10.1002/mus.26052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900968/
https://www.ncbi.nlm.nih.gov/pubmed/29280483
http://dx.doi.org/10.1002/mus.26052

Ejemplares similares